Moleculin Biotech sets 1-for-20 reverse stock split for Oct. 20
Moleculin Biotech, Inc. (NASDAQ: MBRX) announced it has filed an amendment to its certificate of incorporation with the Delaware Secretary ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

